222 related articles for article (PubMed ID: 28640818)
1. Ankylosing spondylitis patients at risk of poor radiographic outcome show diminishing spinal radiographic progression during long-term treatment with TNF-α inhibitors.
Maas F; Arends S; Wink FR; Bos R; Bootsma H; Brouwer E; Spoorenberg A
PLoS One; 2017; 12(6):e0177231. PubMed ID: 28640818
[TBL] [Abstract][Full Text] [Related]
2. Spinal radiographic progression in patients with ankylosing spondylitis treated with TNF-α blocking therapy: a prospective longitudinal observational cohort study.
Maas F; Spoorenberg A; Brouwer E; Bos R; Efde M; Chaudhry RN; Veeger NJ; van Ooijen PM; Wolf R; Bootsma H; van der Veer E; Arends S
PLoS One; 2015; 10(4):e0122693. PubMed ID: 25879956
[TBL] [Abstract][Full Text] [Related]
3. Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors.
Maas F; Arends S; Brouwer E; Essers I; van der Veer E; Efde M; van Ooijen PMA; Wolf R; Veeger NJGM; Bootsma H; Wink FR; Spoorenberg A
Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1011-1019. PubMed ID: 27696754
[TBL] [Abstract][Full Text] [Related]
4. Radiographic damage and progression of the cervical spine in ankylosing spondylitis patients treated with TNF-α inhibitors: Facet joints vs. vertebral bodies.
Maas F; Spoorenberg A; Brouwer E; van der Veer E; Bootsma H; Bos R; Wink FR; Arends S
Semin Arthritis Rheum; 2017 Apr; 46(5):562-568. PubMed ID: 28040243
[TBL] [Abstract][Full Text] [Related]
5. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study.
Ramiro S; Stolwijk C; van Tubergen A; van der Heijde D; Dougados M; van den Bosch F; Landewé R
Ann Rheum Dis; 2015 Jan; 74(1):52-9. PubMed ID: 23956249
[TBL] [Abstract][Full Text] [Related]
6. Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years.
Poddubnyy D; Fedorova A; Listing J; Haibel H; Baraliakos X; Braun J; Sieper J
J Rheumatol; 2016 Dec; 43(12):2142-2148. PubMed ID: 27803139
[TBL] [Abstract][Full Text] [Related]
7. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort.
Molnar C; Scherer A; Baraliakos X; de Hooge M; Micheroli R; Exer P; Kissling RO; Tamborrini G; Wildi LM; Nissen MJ; Zufferey P; Bernhard J; Weber U; Landewé RBM; van der Heijde D; Ciurea A;
Ann Rheum Dis; 2018 Jan; 77(1):63-69. PubMed ID: 28939631
[TBL] [Abstract][Full Text] [Related]
8. Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis.
Baraliakos X; Haibel H; Listing J; Sieper J; Braun J
Ann Rheum Dis; 2014 Apr; 73(4):710-5. PubMed ID: 23505240
[TBL] [Abstract][Full Text] [Related]
9. Impact of Dose Tapering of Tumor Necrosis Factor Inhibitor on Radiographic Progression in Ankylosing Spondylitis.
Park JW; Kwon HM; Park JK; Choi JY; Lee EB; Song YW; Lee EY
PLoS One; 2016; 11(12):e0168958. PubMed ID: 28033420
[TBL] [Abstract][Full Text] [Related]
10. Impact of Tumor Necrosis Factor Inhibitor Versus Nonsteroidal Antiinflammatory Drug Treatment on Radiographic Progression in Early Ankylosing Spondylitis: Its Relationship to Inflammation Control During Treatment.
Park JW; Kim MJ; Lee JS; Ha YJ; Park JK; Kang EH; Lee YJ; Song YW; Lee EY
Arthritis Rheumatol; 2019 Jan; 71(1):82-90. PubMed ID: 29984487
[TBL] [Abstract][Full Text] [Related]
11. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.
Ramiro S; van der Heijde D; van Tubergen A; Stolwijk C; Dougados M; van den Bosch F; Landewé R
Ann Rheum Dis; 2014 Aug; 73(8):1455-61. PubMed ID: 24812292
[TBL] [Abstract][Full Text] [Related]
12. Serum C-reactive Protein Levels Demonstrate Predictive Value for Radiographic and Magnetic Resonance Imaging Outcomes in Patients with Active Ankylosing Spondylitis Treated with Golimumab.
Braun J; Baraliakos X; Hermann KG; Xu S; Hsu B
J Rheumatol; 2016 Sep; 43(9):1704-12. PubMed ID: 27422890
[TBL] [Abstract][Full Text] [Related]
13. Effect of tumor necrosis factor α inhibitors on spinal radiographic progression in patients with ankylosing spondylitis.
Jeong H; Eun YH; Kim IY; Park EJ; Kim H; Lee J; Jeon CH; Koh EM; Cha HS
Int J Rheum Dis; 2018 May; 21(5):1098-1105. PubMed ID: 29611287
[TBL] [Abstract][Full Text] [Related]
14. Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab.
Baraliakos X; Listing J; Rudwaleit M; Brandt J; Sieper J; Braun J
Ann Rheum Dis; 2005 Oct; 64(10):1462-6. PubMed ID: 15778240
[TBL] [Abstract][Full Text] [Related]
15. Incorporating assessment of the cervical facet joints in the modified Stoke ankylosing spondylitis spine score is of additional value in the evaluation of spinal radiographic outcome in ankylosing spondylitis.
Maas F; Arends S; Brouwer E; Bootsma H; Bos R; Wink FR; Spoorenberg A
Arthritis Res Ther; 2017 Apr; 19(1):77. PubMed ID: 28441960
[TBL] [Abstract][Full Text] [Related]
16. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis.
Poddubnyy D; Haibel H; Listing J; Märker-Hermann E; Zeidler H; Braun J; Sieper J; Rudwaleit M
Arthritis Rheum; 2012 May; 64(5):1388-98. PubMed ID: 22127957
[TBL] [Abstract][Full Text] [Related]
17. Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximab.
Baraliakos X; Listing J; Brandt J; Haibel H; Rudwaleit M; Sieper J; Braun J
Rheumatology (Oxford); 2007 Sep; 46(9):1450-3. PubMed ID: 17623745
[TBL] [Abstract][Full Text] [Related]
18. Although female patients with ankylosing spondylitis score worse on disease activity than male patients and improvement in disease activity is comparable, male patients show more radiographic progression during treatment with TNF-α inhibitors.
van der Slik B; Spoorenberg A; Wink F; Bos R; Bootsma H; Maas F; Arends S
Semin Arthritis Rheum; 2019 Apr; 48(5):828-833. PubMed ID: 30253878
[TBL] [Abstract][Full Text] [Related]
19. The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis.
Haroon N; Inman RD; Learch TJ; Weisman MH; Lee M; Rahbar MH; Ward MM; Reveille JD; Gensler LS
Arthritis Rheum; 2013 Oct; 65(10):2645-54. PubMed ID: 23818109
[TBL] [Abstract][Full Text] [Related]
20. Radiographic progression in patients with ankylosing spondylitis according to tumor necrosis factor blocker exposure: Observation Study of Korean Spondyloarthropathy Registry (OSKAR) data.
Kim TJ; Shin JH; Kim S; Sung IH; Lee S; Song Y; Kim TH
Joint Bone Spine; 2016 Oct; 83(5):569-72. PubMed ID: 26948670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
